Search

Displaying results 9331 - 9340 of 10000 in total
  1. Drug

    4-isothioureidobutyronitrile

    go.drugbank.com/drugs/DB13010
    Investigational

    Thioureidobutyronitrile has been used in trials studying the treatment of Solid Tumors and Ovarian cancer.

  2. Drug

    Lodenafil carbonate

    go.drugbank.com/drugs/DB11927
    Investigational

    Lodenafil carbonate has been used in trials studying the treatment of Coronaropathy and Erectile Dysfunction.

  3. Drug

    AZD-4818

    go.drugbank.com/drugs/DB12002
    Investigational

    AZD4818 has been used in trials studying the treatment of Chronic Obstructive Pulmonary Disease (COPD).

  4. Drug

    Fosdagrocorat

    go.drugbank.com/drugs/DB12198
    Investigational

    Fosdagrocorat has been used in trials studying the treatment and basic science of Rheumatoid Arthritis.

  5. Drug

    Begacestat

    go.drugbank.com/drugs/DB12263
    Investigational

    Begacestat has been used in trials studying the treatment and basic science of Alzheimer Disease.

  6. Drug

    Edicotinib

    go.drugbank.com/drugs/DB12504
    Investigational

    JNJ-40346527 has been used in trials studying the treatment of Health and Arthritis, Rheumatoid.

  7. Drug

    AZD-9056

    go.drugbank.com/drugs/DB12594
    Investigational

    AZD9056 has been used in trials studying the basic science and treatment of Rheumatoid Arthritis.

  8. Drug

    Gevokizumab

    go.drugbank.com/drugs/DB12119
    Investigational

    Gevokizumab has been used in trials studying the treatment of Acne Vulgaris, Osteoarthritis, Behcet's Uveitis, Pyoderma Gangrenosum, and Behcet's Disease Uveitis, among others. … Gevokizumab acts as a modulator of cytokine imbalance in IL-1 mediated disease states. It has a very high binding affinity of 300fM and blocks the activation of IL-1 receptors.

  9. Drug

    N2-[(benzyloxy)carbonyl]-n1-[(3S)-1-cyanopyrrolidin-3-yl]-l-leucinamide

    go.drugbank.com/drugs/DB03456
    Experimental

    This compound belongs to the n-acyl-alpha amino acids and derivatives. … These are compounds containing an alpha amino acid (or a derivative thereof) which bears an acyl group at its terminal nitrogen atom. It is known to target cathepsin K.

  10. Drug

    Psilocybin

    go.drugbank.com/drugs/DB11664
    Investigational

    In November, 2019, it was granted Breakthrough Therapy status by the FDA.